Medtronic launches a new clinical trial examining renal denervation as a treatment for hypertension, aiming to settle the 'confounding factors' that led to the failure of its Symplicity-3 trial.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1MzCsg5
Cap comentari:
Publica un comentari a l'entrada